A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis
Recruiting · Phase 3 · NCT06293053
Conditions: Prurigo Nodularis
At a glance
- Research payments reported, 2025
- $214,763
- U.S. investigators named
- 10
- Sites paid
- 10
- Planned or actual enrollment
- 18
About the trial
- Sponsor
- Sanofi (with Regeneron Pharmaceuticals)
- Tested
- Dupilumab (drug)
- Dates
- Started 2024-05-15; completion 2027-11-03
- Results posted
- Not yet
This is a Phase 3, multicenter, open-label, pharmacokinetics (PK)/safety study. The study consists of 3 periods: * Screening period: 2 to 4 weeks. * Treatment period: 24 weeks. * Post-intervention follow-up period: 16 weeks. The study duration will be approximately 42 to 44 weeks for each participant (including screening, treatment, and follow-up periods). The total number of planned study visits for each participant will be 6.
From ClinicalTrials.gov, last updated 2026-10-13. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Sanofi US Services Inc. reported $214,763 in research payments for this study in 2025 (29 payments).
Products named: Dupixent
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Shireen V. Guide, MD Dermatology · Palo Alto, CA
- Sharon E. Albers, MD Dermatology · Tampa, FL
- Frank A. Don, D.O. Dermatology · Hallandale Beach, FL
- Mercedes E. Gonzalez, M.D. Dermatology · Miami, FL
- Pearl C. Kwong, MD PHD Dermatology · Jacksonville, FL
- Eli R. Saleeby, MD Mohs Surgery · Coral Springs, FL
- Kristin Lee, MD Dermatology · Chicago, IL
- Emily M. Becker, M.D. Dermatology · San Antonio, TX
- John C. Browning, MD Dermatology · San Antonio, TX
- Lucia Z. Diaz, M.D. Dermatology · Austin, TX
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Direct Helpers Medical Center Inc Direct Helpers Research Center $37,200
- Shireen V Guide MD Inc Mission Dermatology Center $37,125
- Corazon Usa Llc Dba Life Clinical Trials $34,750
- Ascension Seton Medical Center Austin, TX $21,313
- Driscoll Childrens Hospital, TX $20,651
- Suncoast Holdings Target Llc $19,950
- Texas Dermatology and Laser Special $18,344
- Tareen Dermatology $12,300
- Pediatric Skin Research Llc $7,631
- University of South Florida $5,500
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.